Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject

Clinical Infectious Diseases

Volumn 45, Issue 12, 2007, Pages 1654-1655

  Bonora, Stefano ^a   Calcagno, Andrea ^a   Fontana, Silvia ^a   D'Avolio, Antonio ^a   Siccardi, Marco ^a   Gobbi, Federico ^a   Di Perri, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; DIDANOSINE; ENFUVIRTIDE; PHENOBARBITAL; RITONAVIR PLUS TIPRANAVIR; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTICONVULSIVE AGENT; PYRIDINE DERIVATIVE; PYRONE DERIVATIVE; RITONAVIR; TIPRANAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; EPILEPSY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PRIORITY JOURNAL; DRUG CONTRAINDICATION; DRUG INTERACTION; MIDDLE AGED;

ANTI-HIV AGENTS; ANTICONVULSANTS; DRUG INTERACTIONS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHENOBARBITAL; PYRIDINES; PYRONES; RITONAVIR;

EID: 40449118055     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/523722     Document Type: Letter

References (6)

1. King JR, Acosta EP. Tipranavir: a novel nonpeptidic protease inhibitor of HIV. Clin Pharmacokinet 2006; 45:665-82.
2. Goto S, Seo T, Murata T, et al. Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese. Ther Drug Monit 2007; 29:118-21.
3. Vourvahis M, Kashuba AD. Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir. Pharmacotherapy 2007; 27:888-909.
4. Hsu A, Granneman GR, Bertz RJ. Ritonavir: clinical pharmacokinetics and interactions with other anti-HIV agents. Clin Pharmacokinet 1998; 35:275-91.
5. Lim ML, Min SS, Eron JJ, et al. Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction. J Acquir Immune Defic Syndr 2004; 36:1034-40.
6. Liedtke MD, Lockhart SM, Rathbun RC. Anticonvulsant and antiretroviral interactions. Ann Pharmacother 2004; 38:482-9.